Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2002 | 1 |
2003 | 1 |
2024 | 0 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Page 1
Labeled EGFr-TK irreversible inhibitor (ML03): in vitro and in vivo properties, potential as PET biomarker for cancer and feasibility as anticancer drug.
Int J Cancer. 2002 Oct 1;101(4):360-70. doi: 10.1002/ijc.10619.
Int J Cancer. 2002.
PMID: 12209961
Free article.
Radiosynthesis of ML03 (N-[4-[(4,5-dichloro-2-fluorophenyl)amino]quinazolin-6-yl]acrylamide), an irreversible EGFr-TK inhibitor, was developed. ...
Radiosynthesis of ML03 (N-[4-[(4,5-dichloro-2-fluorophenyl)amino]quinazolin- …
Radiosynthesis of ML03, a novel positron emission tomography biomarker for targeting epidermal growth factor receptor via the labeling synthon: [11C]acryloyl chloride.
Ben-David I, Rozen Y, Ortu G, Mishani E.
Ben-David I, et al.
Appl Radiat Isot. 2003 Feb;58(2):209-17. doi: 10.1016/s0969-8043(02)00301-9.
Appl Radiat Isot. 2003.
PMID: 12573320
Item in Clipboard
Cite
Cite